Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib

Completed

Conditions studied: Advanced Nonsmall Cell Lung Cancer

In brief

Studying samples of blood in the laboratory from patients receiving erlotinib may help doctors learn more about the effects of erlotinib on hormone levels. This clinical trial is looking at hormone changes in women with stage IIIB or stage IV non-small cell lung cancer receiving erlotinib.

Key facts

Study ID

NCT00602433

Run by

Northwestern University

People needed

10

Starts

2007-12-01

Expected to finish

2009-08-01

Last updated by the study team

2011-04-15

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Northwestern University, Northwestern Medical Faculty Foundation — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.